Tata Steel shares in focus after company unveils Rs 27,000-crore Kalinganagar expansion, boosts capacity to 8MT
Tata Steel shares will be in focus on Friday after the company launched the second phase of its Kalinganagar plant in Odisha, increasing its annual crude steel capacity from 3 million tonnes (MT) to 8MT with an investment of Rs 27,000 crore. With this move, Odisha has become Tata Steel's largest investment destination.
ADVERTISEMENT Located in Jajpur district, the expanded facility will produce advanced high-strength steel for sectors such as automotive, infrastructure, power, shipbuilding, and defence.
Tata Steel CEO & MD T.V. Narendran said, "Kalinganagar is more than a manufacturing site for us. It symbolises what is possible when communities, government, and industry work together. This expansion reflects our deep belief in Odisha's potential and our long-term commitment to this state."
Earlier this month, Tata Steel reported a consolidated net profit of Rs 1,201 crore for the quarter ended March 2025, beating Street estimates of Rs 1,062 crore. Revenue from operations came in at Rs 56,218 crore, down 4.2% from Rs 58,687 crore in the same quarter last year, but up 5% sequentially from Rs 53,648 crore in Q3FY25.EBITDA for the quarter came in at Rs 6,762 crore, up from Rs 6,631 crore in Q4FY24 and Rs 5,994 crore in Q3FY25. However, adjusted EBITDA per tonne fell to Rs 7,810, compared to Rs 9,263 in Q3FY25 and Rs 8,735 in Q4FY24.Tata Steel also announced plans to invest up to $2.5 billion in its Singapore-based subsidiary, T Steel Holdings Pte Ltd, as part of its ongoing international strategic initiatives.
ADVERTISEMENT
Also Read: RIL, SBI among 10 stocks with more than 32 buy calls
According to Trendlyne, the average target price for Tata Steel is Rs 161. Out of 30 analysts covering the stock, the consensus rating is 'Buy'.
ADVERTISEMENT Tata Steel shares closed at Rs 161.20 on Thursday, down 0.22% on the BSE. The stock is up 18% year-to-date and has gained 54% over the past two years. Its current market capitalisation stands at Rs 2,01,295 crore.
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)
ADVERTISEMENT
(You can now subscribe to our ETMarkets WhatsApp channel)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
20 minutes ago
- Time of India
Blake Lively faces more legal trouble as her beauty brand strikes back with lawsuit - here's what the problem is
Blake Lively apparently is at the heart of multiple controversies lately. Blake Lively's beauty business is going through a lot of trouble. Family Hive LLC , her company, just filed a trademark lawsuit and is also dealing with the fallout from a well-known harassment case. Lively is having a rough time both personally and professionally. Her business is trying to protect its name, but sales are falling and she is still in legal trouble with co-star Justin Baldoni . Why is Blake Lively's brand suing another company? Blake Brown , Blake Lively's growing hair care company, is in a trademark fight with a company based in Utah. According to recent court filings, Utah-based businesswoman Kimberlie Hamner, the owner of the Beauty by Blake trademark, is being sued by Lively's company, Family Hive LLC. The haircare brand Blake Lively is fighting to stop the competition's "Beauty By Blake" trademark. According to the lawsuit, consumers may become confused by Hamner's trademark because it is too similar to Blake Lively's brand name, as quoted in a report by the Blast. Live Events The Blake Brown product line was formally introduced at Target this summer, but the trademarks were all submitted in 2023 and are still pending approval. Notably, following Blake Lively's filings, Hamner submitted her Beauty by Blake trademark application in September 2024 with the intention of marketing "cosmetic oils" and "serums for cosmetic purposes." What did the court documents reveal? Leo M. Loughlin, the lawyer for Family Hive, stated in the document that was obtained by the Daily Mail that the competing trademark presents a likelihood of confusion and has the potential to damage the Blake Brown brand. He added that Hamner has "no connection whatsoever" to Family Hive and that his products could give consumers the false impression that the company is associated with or supports them. ALSO READ: As Musk exits, DOGE employees are being booted from offices; many fired staff now being rehired How has the lawsuit with Justin Baldoni affected her business? Following her sexual harassment lawsuit against Justin Baldoni in December 2024, Blake Lively's hair-care brand saw a sharp decline in sales, reportedly falling by as much as 78%. This latest lawsuit comes at a challenging time for her business endeavors. The brand was once thought to be worth $100 million, but it is now predicted that Blake Brown will make less than $15 million in total sales in 2025. Lively's brand is still growing in the beauty industry, but the actress is currently balancing her business endeavors with courtroom drama. It's obvious that Blake Brown's future could be as complicated as a bad hair day, especially with trademark tensions escalating. FAQs What is Blake Lively's beauty brand suing for? Her company claims that another brand's name, Beauty by Blake, is too similar and could confuse customers. Is Blake's business struggling? Yes, sales have decreased significantly, particularly since her lawsuit against actor Justin Baldoni made headlines. Economic Times WhatsApp channel )
Time of India
22 minutes ago
- Time of India
Luxury skincare expansion: L'Oreal acquires majority stake in Medik8; announces 1 billion Euro deal
Cosmetics maker L'Oreal agreed to acquire a majority stake in British skincare brand Medik8, in a strategic move to strengthen its presence in the booming skincare market. The French beauty giant announced the deal on Monday, though financial terms were not disclosed. The transaction, which sees UK-based private equity firm Inflexion selling its majority holding, reportedly values Medik8 at around 1 billion Euro, according to a source familiar with the matter. Inflexion will retain a minority share, while L'Oreal has secured the option to eventually buy out all remaining shareholders, Reuters reported. 'We are delighted to welcome Medik8 to the L'Oréal family. As a premium skincare range, with high levels of proven efficacy at an accessible price point, Medik8 perfectly complements our existing skincare portfolio,' Cyril Chaupuy, president of L'oreal Luxe said. 'This acquisition further strengthens L'Oreal's luxe portfolio, adding a premium science-backed skincare brand with a proven track record of success, with strong potential for global growth,' the company said in a statement. L'Oreal will begin consolidating Medik8's sales once the transaction officially closes. The acquisition is expected to be finalised in the coming months, pending regulatory approvals and standard closing conditions. Simon Coble, CEO of Medik8 also expressed excitement on the brand's behalf. 'I am delighted to be joining forces with a company which shares our vision for the brand's future growth and whose core values align with our deep commitment to science, innovation and above all, results without compromise. I look forward to the next stage in Medik8's journey, as we work together to bring our innovative products to a wider audience.' Founded in the UK, Medik8 has built a loyal customer base with its vitamin A-focused anti-ageing creams and serums. The brand is seen as a natural fit for L'Oreal's luxury division, which includes skincare and fragrance names such as Lancome, Aesop, and Miu Miu. Last year, sales in L'Oreal's luxe segment grew by just 2.7%, its weakest performance across divisions, as inflation pushed consumers toward more affordable alternatives. However, the unit scrored better than rival LVMH's beauty arm. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now
Economic Times
24 minutes ago
- Economic Times
How China's craze for Pakistani donkeys is crushing the cash-strapped country's poor
Ejiao demand fuels price hike Live Events Livelihood at stake Chinese interest and ethical concerns What about meat concerns? (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel Abdul Rasheed is in trouble. Last week, his donkey named Tiger, his only source of income, died in an accident. Without a donkey cart, Rasheed has no way to earn money. But buying a new donkey is now a big problem. Prices have shot up to as high as Rs 2 lakh in Karachi and other parts of Pakistan, far more than the Rs 30,000 he paid for Tiger eight years is not alone. Many other poor workers who rely on donkeys for their daily earnings are facing the same crisis. The reason? A growing demand from China, which uses donkey skin to make a traditional medicine called ejiao. It is believed to help with fatigue, improve immunity, reduce tumours, and treat ejiao industry has seen a huge boom. With not enough donkeys at home, Chinese buyers are turning to Pakistan, where donkeys are cheaper and easier to per a PTI report, Dr Guo Jing Feng, who runs a medical centre in Karachi, said China's need for donkey hides is only going to increase. 'This is now a global trade,' he explained, 'and China's demand is much higher than its supply.'Even in the Lyari market, Pakistan's biggest donkey market, prices have jumped. Rasheed says the cheapest healthy donkey he could find was Rs 1.55 lakh. 'How can I afford that? Even if I somehow buy one, what if it dies before I recover my investment?'Donkeys are vital for many industries in Pakistan, from brick kilns and agriculture to transport and even laundry services. Workers like Samad use them to carry heavy loads across rough roads, earning Rs 1,500–2,000 a day, half of which goes into feeding and caring for the around 5.9 million working donkeys, Pakistan is home to the third largest donkey population in the world, after Ethiopia and April 2025, a Chinese delegation met with Pakistan's food security minister to discuss setting up donkey farms. The idea is to use local labour for care and management, which could help Pakistan's not everyone agrees. Dr Asal Khan, a senior official from Khyber Pakhtunkhwa, said some Chinese companies had shown interest in exporting donkeys, but 'we are not allowing that to happen.'Donkey traders say some Chinese buyers are even willing to purchase weak animals just for their hides. In one case, a group paid Rs 40,000 each for 14 unhealthy issues also remain. Saleem Reza of the Karachi Chamber of Commerce says there must be strict rules. 'Donkey meat is haram for us,' he said. 'The government must ensure donkeys are not slaughtered in Pakistan and their meat is not sold illegally.'He added that proper factories are needed to manage hide and meat processing, to make sure nothing enters local markets from PTI
